within Pharmacolibrary.Drugs.ATC.V;

model V09IX09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 6.0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 185 / 1000000,
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Gallium (68Ga) edotreotide is a radiolabeled somatostatin analog used as a diagnostic imaging agent in positron emission tomography (PET) for the localization of somatostatin receptor-positive neuroendocrine tumors. It is not a therapeutic drug, but a diagnostic agent. The agent is currently in clinical use for neuroendocrine tumor imaging.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult human subjects based on typical PET radiotracer characteristics and published data on closely related radiolabeled somatostatin analogues; no direct PK studies for (68Ga) edotreotide are available.</p><h4>References</h4><ol><li><p>Shastry, M, et al., &amp; Bomanji, JB (2010). Distribution pattern of 68Ga-DOTATATE in disease-free patients. <i>Nuclear medicine communications</i> 31(12) 1025–1032. DOI:<a href=&quot;https://doi.org/10.1097/MNM.0b013e32833f635e&quot;>10.1097/MNM.0b013e32833f635e</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/20926978/&quot;>https://pubmed.ncbi.nlm.nih.gov/20926978</a></p></li><li><p>Hartmann, H, et al., &amp; Brogsitter, C (2014). Dosimetric measurements of (68)Ga-high affinity DOTATATE: twins in spirit - part III. <i>Nuklearmedizin. Nuclear medicine</i> 53(5) 211–216. DOI:<a href=&quot;https://doi.org/10.3413/Nukmed-0667-14-05&quot;>10.3413/Nukmed-0667-14-05</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25029274/&quot;>https://pubmed.ncbi.nlm.nih.gov/25029274</a></p></li><li><p>Zhu, W, et al., &amp; Huo, L (2020). Head-to-Head Comparison of . <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 61(6) 897–903. DOI:<a href=&quot;https://doi.org/10.2967/jnumed.119.235093&quot;>10.2967/jnumed.119.235093</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31676731/&quot;>https://pubmed.ncbi.nlm.nih.gov/31676731</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09IX09;
